ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,955Medicare Part D Prescriptions Filled, Including Refills

Rank: 186 out of 2035

$564K Total Retail Price of All Prescriptions

Rank: 233 out of 2035

384 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

34% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 8,510 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 593 556 1 1
HYDROCODONE-ACETAMINOPHEN 373 255 S3 2 2
METOPROLOL TARTRATE 346 279 3 8
FUROSEMIDE 259 226 4 7
LEVOTHYROXINE SODIUM 246 230 5 4
LISINOPRIL 216 175 6 3
AMLODIPINE BESYLATE 202 173 7 6
OMEPRAZOLE 197 155 8 5
PANTOPRAZOLE SODIUM 185 176 9 42
ALCOHOL SWABS 162 121 10 182
GABAPENTIN 161 136 11 14
CARVEDILOL 142 137 12 22
HYDRALAZINE HCL 141 109 13 45
DONEPEZIL HCL 124 119 14 24
POTASSIUM CHLORIDE 122 120 15 18
QUETIAPINE FUMARATE 120 99 16 70
HYDROCHLOROTHIAZIDE 117 111 17 12
METFORMIN HCL 99 81 18 9
ISOSORBIDE MONONITRATE ER 98 95 19 32
WARFARIN SODIUM 96 95 20 11
ACETAMINOPHEN-CODEINE 96 92 S3 20 52
TRAMADOL HCL 95 73 22 19
GLIPIZIDE 95 80 22 54
CITALOPRAM HBR 95 84 22 20
SPIRONOLACTONE 94 88 25 65
PROAIR HFA 93 69 26 31
ENALAPRIL MALEATE 91 87 27 60
RISPERIDONE 90 84 28 68
POLYETHYLENE GLYCOL 3350 89 79 29 48
NIFEDIPINE ER 85 80 30 98
NAMENDA 84 84 31 37
ABILIFY 81 80 32 174
ZOLPIDEM TARTRATE 72 65 33 21
CYCLOBENZAPRINE HCL 70 54 R 34 64
LEVETIRACETAM 68 53 35 87
TAMSULOSIN HCL 68 65 35 25
INSULIN SYRINGE 67 45 37 97
DIVALPROEX SODIUM ER 67 50 37 226
CYMBALTA 65 49 39 59
CLOPIDOGREL 63 60 40 30
SPIRIVA 63 61 40 44
BENZTROPINE MESYLATE 62 61 R 42 223
CLONIDINE HCL 61 51 43 61
ADVAIR DISKUS 60 54 44 38
ZETIA 59 46 45 84
OLANZAPINE ODT 59 54 45 304
LACTULOSE 59 51 45 96
METOPROLOL SUCCINATE 59 40 45 16
MIRTAZAPINE 56 51 49 46
DIVALPROEX SODIUM 56 28 49 75
OXYBUTYNIN CHLORIDE 55 55 51 102
LOSARTAN POTASSIUM 55 53 51 15
LANTUS 53 47 53 40
HUMALOG 52 39 54 139
FAMOTIDINE 51 50 55 71
MEGESTROL ACETATE 50 50 R 56 175
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.